EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction

Nicholas K Brownell, Boback Ziaeian, Gregg C Fonarow

Cardiac Failure Review · 26.11.2021 · 7

DOI: 10.15420/cfr.2021.18 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 26.11.2021. Verfasst von Nicholas K Brownell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of California Los Angeles (UCLA) Los Angeles, CA, US. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are gaps in the use of therapies that save lives and improve quality of life for patients with heart failure with reduced ejection fraction, both in the US and abroad. The evidence is clear that initiation and titration of guideline-directed medical therapy (GDMT) and comprehensive disease-modifying medical therapy (CDMMT) to maximally tolerated doses improves patient-focused outcomes, yet observational data suggest this does not happen. The purpose of this review is to describe the gap in the use of optimal treatment worldwide and discuss the benefits of newer heart failure therapies including angiotensin receptor-neprilysin inhibitors and sodium-glucose cotransporter 2 inhibitors. It will also cover the efficacy and safety of such treatments and provide potential pathways for the initiation and rapid titration of GDMT/CDMMT.

Schlagwörter

Stichwörter der Autor:innen

Heart failurecomprehensive disease-modifying medical therapycost benefitsearly treatment initiationguideline-directed medical therapyrates of use

Autor:innen und Institutionen

  • Division of Cardiology, University of California Los Angeles (UCLA) Los Angeles, CA, US.
  • Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, CA, US.

Zitieren

APA

Brownell, N. K., Ziaeian, B., & Fonarow, G. C. (2021). The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction. Cardiac Failure Review, 7. https://doi.org/10.15420/cfr.2021.18

Vancouver

Brownell NK, Ziaeian B, Fonarow GC. The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction. Cardiac Failure Review. 2021;7. doi:10.15420/cfr.2021.18

BibTeX
@article{Brownell2021,
  author = {Brownell, Nicholas K and Ziaeian, Boback and Fonarow, Gregg C},
  title = {The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction},
  journal = {Cardiac Failure Review},
  year = {2021},
  volume = {7},
  doi = {10.15420/cfr.2021.18}
}
Kostenlos starten →